1. Home
  2. STOK vs BLDP Comparison

STOK vs BLDP Comparison

Compare STOK & BLDP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • STOK
  • BLDP
  • Stock Information
  • Founded
  • STOK 2014
  • BLDP 1979
  • Country
  • STOK United States
  • BLDP Canada
  • Employees
  • STOK N/A
  • BLDP N/A
  • Industry
  • STOK Biotechnology: Pharmaceutical Preparations
  • BLDP Industrial Machinery/Components
  • Sector
  • STOK Health Care
  • BLDP Energy
  • Exchange
  • STOK Nasdaq
  • BLDP Nasdaq
  • Market Cap
  • STOK 517.0M
  • BLDP 413.8M
  • IPO Year
  • STOK 2019
  • BLDP 1995
  • Fundamental
  • Price
  • STOK $11.58
  • BLDP $1.52
  • Analyst Decision
  • STOK Strong Buy
  • BLDP Sell
  • Analyst Count
  • STOK 5
  • BLDP 11
  • Target Price
  • STOK $24.50
  • BLDP $1.71
  • AVG Volume (30 Days)
  • STOK 534.4K
  • BLDP 10.6M
  • Earning Date
  • STOK 08-06-2025
  • BLDP 08-11-2025
  • Dividend Yield
  • STOK N/A
  • BLDP N/A
  • EPS Growth
  • STOK N/A
  • BLDP N/A
  • EPS
  • STOK 0.88
  • BLDP N/A
  • Revenue
  • STOK $190,908,000.00
  • BLDP $70,668,000.00
  • Revenue This Year
  • STOK $378.84
  • BLDP $43.80
  • Revenue Next Year
  • STOK N/A
  • BLDP $25.81
  • P/E Ratio
  • STOK $13.21
  • BLDP N/A
  • Revenue Growth
  • STOK 2333.81
  • BLDP N/A
  • 52 Week Low
  • STOK $5.35
  • BLDP $1.00
  • 52 Week High
  • STOK $16.15
  • BLDP $2.72
  • Technical
  • Relative Strength Index (RSI)
  • STOK 67.25
  • BLDP 52.21
  • Support Level
  • STOK $11.43
  • BLDP $1.58
  • Resistance Level
  • STOK $12.25
  • BLDP $1.80
  • Average True Range (ATR)
  • STOK 0.51
  • BLDP 0.11
  • MACD
  • STOK 0.02
  • BLDP -0.00
  • Stochastic Oscillator
  • STOK 75.90
  • BLDP 50.00

About STOK Stoke Therapeutics Inc.

Stoke Therapeutics Inc is a biotechnology company dedicated to restoring protein expression by harnessing the body's potential with RNA medicine. Its proprietary TANGO (Targeted Augmentation of Nuclear Gene Output) approach, Stoke is developing antisense oligonucleotides (ASOs) to restore naturally-occurring protein levels selectively. Its first medicine in development, zorevunersen, has demonstrated the potential for disease modification in patients with Dravet syndrome. The company provides early programs focused on multiple targets, including haploinsufficiency diseases of the central nervous system and eye, to up-regulate the protein expression of the underlying disease gene in a mutation-agnostic manner.

About BLDP Ballard Power Systems Inc.

Ballard Power Systems Inc is engaged in design, development, manufacture, sale and service of proton exchange membrane ("PEM") fuel cell products for a variety of applications, focusing on power products for bus, truck, rail, marine, stationary and emerging market (material handling, off-road and other) applications, as well as the delivery of services, including technology solutions, after sales services and training. A fuel cell is an environmentally clean electrochemical device that combines hydrogen fuel with oxygen (from the air) to produce electricity. Key geographical revenue is derived from Poland followed by United States, United Kingdom, and other countries.

Share on Social Networks: